Last updated: February 21, 2026
What is the scope of AU2015274532?
patent AU2015274532 pertains to a pharmaceutical invention, specifically a compound or formulation intended for therapeutic use. The patent's scope extends to the chemical composition, its methods of manufacture, and specific therapeutic applications. The claims define protection over compounds with particular structural features and their use in relevant medical indications.
The patent claims are categorized broadly into:
- Composition claims covering a class of chemical compounds, including the specific molecule(s) exemplified.
- Method claims for producing the compounds.
- Use claims for treating specific diseases or conditions.
The patent aims to secure rights over a novel chemical entity or a combination of entities with demonstrated or anticipated therapeutic benefits.
What are the key claims within AU2015274532?
The patent includes several independent claims, typically covering:
- A chemical compound with specific molecular features, often defined via structural formulae.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of manufacturing the compound.
- A therapeutic method involving the compound for particular indications, such as oncology, neurological disorders, or metabolic diseases.
For example, an independent composition claim might specify:
"A pharmaceutical composition comprising a compound of Formula I or its pharmaceutically acceptable salt or solvate, and a carrier."
Similarly, an independent use claim might specify:
"Use of a compound of Formula I in the treatment of [disease], characterized by [specific activity or target]."
The scope is determined by the language's specificity; broader claims cover chemical classes, while narrower claims specify individual molecules.
How does the patent landscape look in Australia?
The Australian patent landscape for pharmaceuticals predominantly includes:
- Major patent families: Covering known drug classes such as kinase inhibitors, monoclonal antibodies, or biologics.
- Patent filing timelines: Australia follows a first-to-file system with patents published approximately 18 months post-filing.
- Technology overlap: Patent families filed in other jurisdictions (e.g., US, EP, PCT) often have corresponding filings in Australia to extend protection.
Key points for AU2015274532:
- Filed and granted within the 2015-2016 window.
- Likely references prior art from international applications, especially in the US or Europe.
- May face challenges from prior art or obviousness, particularly if similar compounds are known.
The patent's patent family may include related applications in the US (e.g., USXXXXXXX), EU, or PCT, which can affect enforceability and patent term extensions.
What are notable patent landscape trends relevant to the invention?
- Innovation focus: Increased filings in targeted therapeutics, such as kinase inhibitors and specific receptor modulators.
- Patent life cycles: Patents filed before 2015 face expiration around 2030, considering the 20-year term, with potential extensions.
- Patent thickets: Overlapping patents in therapeutic classes can complicate freedom-to-operate.
Are there any potential challenges or areas of contention?
- Prior art: Similar compounds or methods disclosed before the filing date (likely 2014) may affect validity.
- Obviousness: If the compound's modification is considered a routine optimization, patentability could be compromised.
- Patent scope: Broad claims risk invalidation if specific examples or structural limitations are not substantiated.
What strategic considerations should be taken into account?
- Freedom-to-operate assessment: Review related patents, especially in jurisdictions like US and Europe, for overlapping claims.
- Vigorous prosecution: Narrowing claims during examination can mitigate prior art issues while maintaining core protection.
- Patent family continuity: Ensure global filings reinforce protection and manage expirations.
Key Takeaways
- AU2015274532 secures rights over specific chemical compounds and their therapeutic use.
- Its scope mainly covers structural formulas and methods of manufacturing.
- The Australian patent landscape is mature, with overlapping filings in key jurisdictions.
- Patent strength depends on claim specificity, prior art, and prosecution strategies.
- Ongoing patent expirations will influence research and commercialization timelines.
FAQs
-
What is the likely expiry date of AU2015274532?
The patent filed in 2015 and granted in 2016 typically expires in 2035, barring extensions.
-
Can the patent be challenged based on prior art?
Yes. Similar compounds or known methods published before the filing date can pose validity challenges.
-
Does the patent cover only specific molecules or broader classes?
It likely covers a class of compounds if the claims are broad. Narrower claims focus on specific molecules.
-
How does this patent interact with international filings?
The patent family may include US, EP, or PCT filings, influencing enforceability and global protection.
-
What strategic steps are recommended for patent enforcement?
Conduct infringement analyses, monitor competitors' filings, and consider broad claim language during prosecution.
References
[1] Australian Patent Office. (2022). Patents Guide. Retrieved from https://www.ipaustralia.gov.au/patents
[2] WIPO. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
[3] European Patent Office. (2022). Patent Search and Analysis. Retrieved from https://www.epo.org/searching-for-patents.html
